EHMT2 expression was significantly higher in NSCLC, including adenocarcinoma (AD), squamous cell carcinoma (SCC), and large cell lung cancer (LCLC), compared to normal tissue, while it did not show a significant difference in small cell lung cancer (SCLC). This evidence concerns the gene EHMT2 and adenocarcinoma.